Sage Therapeutics Inc
(FRA:SG7)
€
5.452
0.102 (1.91%)
Market Cap: 325.18 Mil
Enterprise Value: -211.07 Mil
PE Ratio: 0
PB Ratio: 0.61
GF Score: 49/100 SAGE Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2023 / 04:15PM GMT
Release Date Price:
€21.8
(+4.81%)
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst
Okay. Let's go ahead and get started. Welcome, everyone. This is the fireside chat with Sage Therapeutics. My name is Vikram Purohit, I'm one of the biotech analysts with Morgan Stanley Research. Before we get started, I am going to let you know of a disclosure for all important disclosures, please see the Morgan Stanley website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your sales representative. With that, happy to have with me Barry Greene from stage. Barry, thanks for joining us.
Barry E. Greene
Sage Therapeutics, Inc. - President, CEO & Director
Yes, Vikram, I really appreciate being here. I thank the organizers of Morgan Stanley for having us. Great to be here in New York with you.
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst
Great. Barry, we have quite a few items to talk
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot